Clinical Trial Update: A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of PQR309 in patients with advanced solid tumors; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PQR309

Snippet

Sponsor: PIQUR Therapeutics AG | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED